Tussilago Farfara (Coltsfoot) Flower Extract

1. Definition Tussilago Farfara (Coltsfoot) Flower Extract:

Tussilago Farfara (Coltsfoot) Flower Extract is a botanical extract derived from the flowers of the Coltsfoot plant. Coltsfoot is a perennial herb that is native to Europe and Asia, known for its traditional medicinal uses in treating respiratory conditions such as coughs and bronchitis.

2. Use:

Coltsfoot Flower Extract is commonly used in cosmetics for its soothing and anti-inflammatory properties. It is believed to help calm irritated skin, reduce redness, and promote overall skin health. Additionally, Coltsfoot Flower Extract is rich in antioxidants, which can help protect the skin from environmental damage and premature aging.

3. Usage Tussilago Farfara (Coltsfoot) Flower Extract:

Coltsfoot Flower Extract can be found in various skincare products such as creams, lotions, serums, and masks. It is typically used in small concentrations and can be applied directly to the skin. However, it is important to perform a patch test before using products containing Coltsfoot Flower Extract to ensure there are no adverse reactions. It is also recommended to consult with a dermatologist before incorporating this ingredient into your skincare routine, especially if you have sensitive skin or existing skin conditions.

4. References:

- Park, S.Y., Lee, J.H., Kim, J.M., Lee, Y.S., Chung, J.H. (2011). Topical application of an ethanol extract prepared from Illicium verum suppresses atopic dermatitis in NC/Nga mice. Journal of Ethnopharmacology, 134(1), 191-197.

- Kwon, Y.S., Kim, K.M., Jang, H.D. (2014). Anti-inflammatory effects of Tussilago farfara L. ethanolic extract through inhibition of NF-κB and MAPK in LPS-stimulated RAW 264.7 macrophages. Natural Product Research, 28(22), 2015-2018.

- Gao, Y., Li, J., Li, J., Wang, J., Zhang, X., Li, J., Zhang, J. (2019). Tussilago farfara L. suppresses inflammatory responses through NF-κB inactivation in LPS-stimulated RAW 264.7 cells and croton oil-treated mouse skin. Pharmaceutical Biology, 57(1), 245-253.